Atlas Trials

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

Clinical trial NCT01609062 · TERMINATED

Trial details

NCT number
NCT01609062
Sponsor
BioMarin Pharmaceutical
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Mucopolysaccharidosis IVAMorquio A SyndromeMPS IVA
Start date
2012-04-01
Primary completion
2014-11-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.